Researchers at the University of Houston are working to make T-cell immunotherapy safer, developing a tool called CrossDome, which uses a combination of genetic and biochemical information to predict if T-cell immunotherapies might mistakenly attack healthy cells.

Related Keywords

Andref Fonseca , Dinler Antunes , Nuclear Receptors , University Of Houston , Computational Biology ,